Callan Family Office’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
Other funds holding LRCX
Callan Family Office's LRCX Position: Q2 2026 in Review
Callan Family Office increased its Lam Research (LRCX) stake by 0.45% in Q2 2026, buying an estimated $49.2K and bringing the position to 35,777 shares worth $15.5M. The position accounts for 0.3% of the portfolio, ranked #63.
Callan Family Office first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Callan Family Office held 35,777 shares of Lam Research worth $15.5M as of Q2 2026.
- Callan Family Office bought 162 Lam Research shares in Q2 2026, an estimated $49.2K.
- Lam Research made up 0.3% of Callan Family Office's portfolio in Q2 2026, its #63 holding.
- Callan Family Office first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
- 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.